GlaxoSmithKline Pharmaceuticals Limited Share Price NSE India S.E.
Stocks
GLAXO
INE159A01016
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,410.80 INR | +0.18% |
|
-1.61% | -2.54% |
| Market Cap | 407B 4.29B 3.75B 3.46B 3.21B 6.09B 6.18B 41.48B 16.13B 201B 16.1B 15.75B 694B | P/E 2027 * |
35.3x | P/E 2028 * | 31.1x |
|---|---|---|---|---|---|
| Enterprise Value | 407B 4.29B 3.75B 3.46B 3.21B 6.09B 6.18B 41.48B 16.13B 201B 16.1B 15.75B 694B | EV / Sales 2027 * |
9.71x | EV / Sales 2028 * | 8.76x |
| Free-Float |
24.36% | Yield 2027 * |
1.23% | Yield 2028 * | 1.23% |
Last Transcript: GlaxoSmithKline Pharmaceuticals Limited
| 1 day | +0.18% | ||
| 1 week | -1.61% | ||
| Current month | -1.61% | ||
| 1 month | +10.39% | ||
| 3 months | +3.32% | ||
| 6 months | -1.99% | ||
| Current year | -2.54% |
| 1 week | 2,370 |  | 2,504.7 |
| 1 month | 2,088.1 | | 2,504.7 |
| Current year | 2,088.1 | | 2,719.8 |
| 1 year | 2,088.1 | | 3,344 |
| 3 years | 1,377.25 | | 3,515.7 |
| 5 years | 1,227 | | 3,515.7 |
| 10 years | 962.65 | | 3,515.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bhushan Akshikar
CEO | Chief Executive Officer | 56 | 30/11/2022 |
Ronojit Biswas
DFI | Director of Finance/CFO | - | 31/03/2026 |
Shalini Menon
CTO | Chief Tech/Sci/R&D Officer | - | 07/07/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Subesh Williams
BRD | Director/Board Member | 64 | 06/04/2017 |
Renu Sud Karnad
CHM | Chairman | 73 | 31/03/2019 |
| Director/Board Member | 59 | 17/05/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.18% | -1.61% | - | - | 4.29B | |
| +2.96% | +3.01% | +59.87% | +173.31% | 1,102B | |
| +3.05% | +5.23% | +72.11% | +67.81% | 643B | |
| -0.04% | +1.20% | +35.72% | +87.93% | 450B | |
| +1.01% | -2.07% | +27.62% | +22.57% | 336B | |
| -0.72% | -0.60% | +28.90% | +48.18% | 288B | |
| -2.50% | +1.32% | -27.75% | -40.64% | 222B | |
| +0.45% | +1.65% | +25.65% | +68.35% | 199B | |
| +5.21% | +7.93% | +21.99% | +83.23% | 169B | |
| +1.48% | -0.04% | -4.64% | -32.25% | 137B | |
| Average | +0.28% | +2.00% | +26.61% | +53.17% | 393.9B | |
| Weighted average by Cap. | +0.07% | +1.86% | +41.76% | +87.39% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 41.94B 442M 387M 356M 330M 627M 637M 4.27B 1.66B 20.7B 1.66B 1.62B 71.54B | 46.45B 489M 428M 395M 366M 695M 706M 4.73B 1.84B 22.93B 1.84B 1.8B 79.24B |
| Net income | 11.51B 121M 106M 97.85M 90.69M 172M 175M 1.17B 456M 5.68B 455M 446M 19.64B | 12.87B 136M 119M 109M 101M 192M 196M 1.31B 510M 6.35B 509M 498M 21.96B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/07/26 | ₹2,410.80 | +0.18% | 89,722 |
| 07/07/26 | ₹2,406.50 | +0.18% | 55,616 |
| 06/07/26 | ₹2,402.20 | +0.28% | 51,678 |
| 03/07/26 | ₹2,395.50 | -0.84% | 57,138 |
| 02/07/26 | ₹2,415.80 | -1.98% | 63,088 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLAXO Stock
- GLAXO Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
